3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Immunoblastic Lymphadenopathy
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
pembrolizumab
11
Specimen Handling
9
enfortumab vedotin
8
Magnetic Resonance Spectroscopy
8
Nivolumab
7
Ipilimumab
4
Gemcitabine
4
sacituzumab govitecan
3
Docetaxel
3
Cisplatin
3
CTLA-4 Antigen
3
cabozantinib
2
atezolizumab
2
Taxes
2
Paclitaxel
2
Mitomycin
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
tislelizumab
1
temsirolimus
1
tazemetostat
1
sapanisertib
1
relatlimab
1
lenvatinib
1
eribulin
1
erdafitinib
1
durvalumab
1
belinostat
1
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
10-propargyl-10-deazaaminopterin
×
30 days
×
Clear all
No trials found.